Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality
Following the successful launch of CQAs in LNP-mRNA Modality, we continue the series with CQA in ADC Modality. This white paper discusses: ADC components, ADC-related CQA, Impact on safety and efficacy.
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512
2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512
CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512
2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512
CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566